These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8314358)
41. [The behavior of central and peripheral hemodynamics in isometric and dynamic stress in hypertensive patients treatment with regular sauna therapy]. Siewert C; Siewert H; Winterfeld HJ; Strangfeld D Z Kardiol; 1994 Sep; 83(9):652-7. PubMed ID: 7801668 [TBL] [Abstract][Full Text] [Related]
42. Coronary hemodynamics and the renin angiotensin system. Magrini F; Reggiani P; Paliotti R; Bonagura F; Ciulla M; Vandoni P Clin Exp Hypertens; 1993; 15 Suppl 1():139-55. PubMed ID: 8513306 [TBL] [Abstract][Full Text] [Related]
43. Haemodynamic effects of AT1 inhibition and Ca2+-channel blockade in hypertensive patients during isometric stress. Arosio E; De Marchi S; Prior M; Rigoni A; Lechi A J Hum Hypertens; 2006 Mar; 20(3):201-5. PubMed ID: 16319906 [TBL] [Abstract][Full Text] [Related]
44. Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure. Uusitupa M; Korhonen M; Litmanen H; Niskanen L; Väisänen S; Rauramaa R J Hum Hypertens; 1996 May; 10(5):319-26. PubMed ID: 8817406 [TBL] [Abstract][Full Text] [Related]
45. ACE inhibition preserves renal function better than beta-blockade in the treatment of essential hypertension. Himmelmann A; Hansson L; Hansson BG; Hedstrand H; Skogström K; Ohrvik J; Furängen A Blood Press; 1995 Mar; 4(2):85-90. PubMed ID: 7599759 [TBL] [Abstract][Full Text] [Related]
46. [Analysis of the variability of arterial pressure in patients with labile and stable hypertension and changes induced with atenolol]. Palatini P; Pessina AC; Semplicini A; Moramio P; Casiglia E; Dal Palù C G Ital Cardiol; 1980; 10(3):301-8. PubMed ID: 7372046 [TBL] [Abstract][Full Text] [Related]
47. [Are home blood pressure measurements and 24-hour ambulatory recordings superior to office measurements? Comparison of 3 blood pressure recording methods in a study of cilazapril versus atenolol]. Schubiger JL; Wohler D; Grüne S; Weisser B; Kraft K; Del Bufalo A; Binswanger B; Mengden T; Spühler T; Greminger P Schweiz Rundsch Med Prax; 1993 May; 82(20):587-92. PubMed ID: 8506440 [TBL] [Abstract][Full Text] [Related]
48. Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial. Punda A; Polić S; Rumboldt Z; Bagatin J; Marković V; Lukin A Croat Med J; 2005 Apr; 46(2):219-24. PubMed ID: 15849842 [TBL] [Abstract][Full Text] [Related]
49. Comparison of effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients. Schiffrin EL; Deng LY Hypertension; 1995 Apr; 25(4 Pt 2):699-703. PubMed ID: 7721419 [TBL] [Abstract][Full Text] [Related]
50. Prazosin enhances the antihypertensive effects of beta-blockers during isometric and dynamic exercise. Aärynen M; Mäkelä M; Hämeenaho P; Mattila MJ Ann Clin Res; 1981 Apr; 13(2):71-6. PubMed ID: 7015988 [TBL] [Abstract][Full Text] [Related]
51. Effects of angiotensin-converting enzyme inhibition versus conventional antihypertensive therapy on the glomerular filtration rate. Hansson L Cardiology; 1995; 86 Suppl 1():30-3. PubMed ID: 7614504 [TBL] [Abstract][Full Text] [Related]
52. Arterial hemodynamics in human hypertension. Ting CT; Brin KP; Lin SJ; Wang SP; Chang MS; Chiang BN; Yin FC J Clin Invest; 1986 Dec; 78(6):1462-71. PubMed ID: 3782467 [TBL] [Abstract][Full Text] [Related]
53. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta-blocker. Schiffrin EL; Deng LY; Larochelle P Am J Hypertens; 1995 Mar; 8(3):229-36. PubMed ID: 7794571 [TBL] [Abstract][Full Text] [Related]
54. [Short term treatment of essential arterial hypertension with atenolol: effect on the renin-angiotensin-aldosterone system and on hemodynamic parameters]. Indovina I; Salerno L; Licata G; Pepe S; Custro N Clin Ter; 1983 Feb; 104(3):223-6. PubMed ID: 6861459 [No Abstract] [Full Text] [Related]
55. [Atenolol, a new beta-adrenergic blocking agent, in treatment of hypertension: therapeutic effect and hemodynamic changes (author's transl)]. Shen JQ Zhonghua Xin Xue Guan Bing Za Zhi; 1981 Jun; 9(2):94-8. PubMed ID: 7032869 [No Abstract] [Full Text] [Related]
56. Hemodynamic consequences of long-term beta-blocker therapy: a 5-year follow-up study of atenolol. Lund-Johansen P J Cardiovasc Pharmacol; 1979; 1(5):487-95. PubMed ID: 94405 [TBL] [Abstract][Full Text] [Related]
57. Impaired vasodilation during long-term beta 1-selective beta-blockade in hypertensive patients. Lenders JW; de Boo T; Lemmens WA; Reyenga J; Thien T Clin Pharmacol Ther; 1988 Aug; 44(2):195-201. PubMed ID: 3396263 [TBL] [Abstract][Full Text] [Related]
58. Hemodynamic and biochemical changes after chronic administration of cilazapril to hypertensive patients. Lefkos N; Efthimiadis A; Liatsis I; Boudonas G; Papachristou A; Platoyannis D Cardiology; 1993; 82(4):249-58. PubMed ID: 8402751 [TBL] [Abstract][Full Text] [Related]
59. Haemodynamic changes during treatment of arterial hypertension with atenolol (Tenormin). Jensen HA; Rasmussen K; Mosbaek N Dan Med Bull; 1980 Jul; 27(3):153-5. PubMed ID: 7438801 [No Abstract] [Full Text] [Related]
60. [A comparison of the efficacy of cilazapril and ramipril in treating arterial hypertension patients (a randomized study)]. Akhadov ShV; Belousov IuB Ter Arkh; 1994; 66(12):17-20. PubMed ID: 7900034 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]